Technology that will change clinical research in the next 10 years
04 February 2015
Social media, patient awareness & self assertion and Electronic Health data will all change how clinical research generally, and clinical trials specifically will be carried out over the next 10 years.
Marinus Pharmaceuticals Initiates Clinical Trial with Ganaxolone in PCDH19 Female Pediatric Epilepsy
03 February 2015
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, announced that it has initiated a Phase 2 clinical trial with ganaxolone, a synthetic analog of the endogenous neurosteroid allopregnanolone, in female children with epilepsy caused by a mutation of the protocadherin 19 gene (PCDH19). PCDH19 female pediatric epilepsy is a rare disease that is estimated to affect approximately 15,000-30,000 females in the U.S. and is characterized by onset of cluster seizures before age 5, cognitive and sensory impairment of varying degrees, and behavioral disturbances.
Ebola Vaccine Trial Opens in Liberia
03 February 2015
A large clinical trial to assess the safety and efficacy of two experimental vaccines to prevent Ebola virus infection is now open to volunteers in Liberia. The trial is being led by a recently formed Liberia-U.S. clinical research partnership and is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Big Pharma farms out safety monitoring to $2B-and-growing industry
03 February 2015
Big Pharma has been hiring out all sorts of functions companies once did in-house: sales, manufacturing, and IT services, to name a few. But according toThe Wall Street Journal, one of the fastest-growing fields for pharma contractors isn't any of these. It's drug safety.
U.K. set to kick off huge genome project with U.S. right behind
03 February 2015
A U.K. project designed to analyze up to 100,000 entire human genomes is set to begin tomorrow with a similar project in the U.S. focused on more than one million people expected to be announced later this week.
NovaDigm Therapeutics, Inc. - Product Pipeline Review - 2014 - New Report Available
02 February 2015
Global Markets Direct's, 'NovaDigm Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the NovaDigm Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NovaDigm Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
China medical device market to top Japan to claim No. 2 spot globally
02 February 2015
China's market for medical devices is expected to pass Japan's this year to become the world's second-largest, topped only by the United States. A consulting firm forecast China's market would pass the $55 billion mark this year, nearly double that of just two years ago.
U.S. proposes effort to analyze DNA from 1 million people
02 February 2015
The United States has proposed analyzing genetic information from more than 1 million American volunteers as part of a new initiative to understand human disease and develop medicines targeted to an individual's genetic make-up.
Financial Scorecard: Biotech and big pharma keep on rolling
30 January 2015
If we thought that biotech's record financing year would be a tough act to follow we might have to revise that notion if the transactions that have been completed so far this month are anything to go by.
Branded drug prices leapt almost 15% last year, led by pain pills, COPD and heart meds
30 January 2015
It's no secret that branded drugmakers often rely on price hikes to keep U.S. sales growth coming, especially on older meds whose patents are close to the ends of their lives. But according to new data, prices spiked more than 10% last year--a trend that may fuel the payer backlash that's been steadily mounting
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
A biotechnology and medicine center has opened in Mordovia
22 January 2025
Long-term potential revealed for novel modifier gene therapy
21 January 2025
Binnopharm Group opened an office in Vietnam
21 January 2025